Atherosclerosis, arterial stiffness and antihypertensive drug therapy.

Michel E Safar, Harold Smulyan
{"title":"Atherosclerosis, arterial stiffness and antihypertensive drug therapy.","authors":"Michel E Safar,&nbsp;Harold Smulyan","doi":"10.1159/000096751","DOIUrl":null,"url":null,"abstract":"<p><p>Increased aortic stiffness is a consequence of cardiovascular (CV) aging and may be observed in the elderly with or without hypertension. Hypertension and arterial stiffness are independent risk factors for CV events, but such events may also be complicated by atherosclerosis, especially in the older population. The purpose of this chapter is to determine whether, in the presence of atherosclerosis, systolic hypertension in the elderly requires specific drug therapy. It will be shown that, in addition to the targeted drug treatment of associated hypercholesterolemia and/or hyperglycemia, the major problem nowadays is to find specific antihypertensive drugs causing a selective reduction of systolic blood pressure (SBP).</p>","PeriodicalId":50954,"journal":{"name":"Advances in Cardiology","volume":"44 ","pages":"331-351"},"PeriodicalIF":0.0000,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000096751","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000096751","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Increased aortic stiffness is a consequence of cardiovascular (CV) aging and may be observed in the elderly with or without hypertension. Hypertension and arterial stiffness are independent risk factors for CV events, but such events may also be complicated by atherosclerosis, especially in the older population. The purpose of this chapter is to determine whether, in the presence of atherosclerosis, systolic hypertension in the elderly requires specific drug therapy. It will be shown that, in addition to the targeted drug treatment of associated hypercholesterolemia and/or hyperglycemia, the major problem nowadays is to find specific antihypertensive drugs causing a selective reduction of systolic blood pressure (SBP).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
动脉粥样硬化,动脉僵硬和降压药物治疗。
主动脉硬化增加是心血管(CV)老化的结果,可能在有或没有高血压的老年人中观察到。高血压和动脉僵硬是心血管事件的独立危险因素,但心血管事件也可能因动脉粥样硬化而复杂化,尤其是在老年人群中。本章的目的是确定在动脉粥样硬化存在的情况下,老年人收缩期高血压是否需要特定的药物治疗。我们将看到,除了针对相关的高胆固醇血症和/或高血糖的药物治疗外,目前的主要问题是寻找特异性降压药,使收缩压(SBP)选择性降低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation. Antiplatelet therapy in stroke prevention. Challenges in atrial fibrillation. Conclusion. Antiplatelet therapy in acute coronary syndrome and atrial fibrillation: aspirin.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1